Tocqueville Asset Management L.P. reduced its stake in UnitedHealth Group Inc (NYSE:UNH) by 40.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 57,931 shares of the healthcare conglomerate’s stock after selling 39,595 shares during the period. Tocqueville Asset Management L.P.’s holdings in UnitedHealth Group were worth $14,136,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently bought and sold shares of UNH. FMR LLC raised its holdings in UnitedHealth Group by 1.9% during the 4th quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock worth $16,063,258,000 after purchasing an additional 1,232,189 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of UnitedHealth Group by 9.1% in the 4th quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after acquiring an additional 965,763 shares in the last quarter. Norges Bank bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at $2,343,175,000. Janus Henderson Group PLC increased its stake in shares of UnitedHealth Group by 16.7% in the 2nd quarter. Janus Henderson Group PLC now owns 6,448,289 shares of the healthcare conglomerate’s stock valued at $1,573,438,000 after acquiring an additional 922,290 shares in the last quarter. Finally, American Century Companies Inc. increased its stake in shares of UnitedHealth Group by 12.8% in the 4th quarter. American Century Companies Inc. now owns 5,678,706 shares of the healthcare conglomerate’s stock valued at $1,414,679,000 after acquiring an additional 644,872 shares in the last quarter. Institutional investors own 85.65% of the company’s stock.
NYSE UNH traded up $4.80 during mid-day trading on Tuesday, hitting $248.00. The company’s stock had a trading volume of 107,641 shares, compared to its average volume of 3,510,335. The firm’s 50 day moving average price is $251.38. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $235.62 billion, a price-to-earnings ratio of 19.29, a price-to-earnings-growth ratio of 1.33 and a beta of 0.61.
UNH has been the subject of several research analyst reports. Royal Bank of Canada set a $311.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Friday, July 19th. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a research note on Friday, July 12th. Cantor Fitzgerald set a $310.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Friday, July 19th. Bank of America reiterated a “buy” rating and issued a $290.00 price objective (down previously from $320.00) on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Finally, SunTrust Banks lowered their price objective on shares of UnitedHealth Group to $300.00 and set a “buy” rating for the company in a research note on Wednesday, April 17th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $295.06.
In related news, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $241.99, for a total value of $2,419,900.00. Following the completion of the sale, the director now owns 187,663 shares of the company’s stock, valued at approximately $45,412,569.37. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of UnitedHealth Group stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the transaction, the director now directly owns 61,309 shares in the company, valued at $15,652,800.79. The disclosure for this sale can be found here. In the last three months, insiders sold 37,000 shares of company stock valued at $9,195,620. 0.82% of the stock is currently owned by insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.